Publications by authors named "Bryan Gillard"

Claim this Profile
I
Inosine monophosphate dehydrogenase 2 (IMPDH2) modulates response to therapy and chemo-resistance in triple negative breast cancer.
Tatiane da Silva Fernandes, Bryan M Gillard, Tao Dai, Jeffrey C Martin, Kanita A Chaudhry

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous CD28 drives CAR T cell responses in multiple myeloma.
Mackenzie M Lieberman, Jason H Tong, Nkechi U Odukwe, Colin A Chavel, Terence J Purdon, Bryan M Gillard

bioRxiv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers.
Mohammed M Alruwaili, Justin Zonneville, Maricris N Naranjo, Hannah Serio, Thomas Melendy, Bryan Gillard

Cell Rep Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aryl hydrocarbon receptor is a tumor promoter in -amplified neuroblastoma cells through suppression of differentiation.
Kanita A Chaudhry, Justine J Jacobi, Bryan M Gillard, Ellen Karasik, Jeffrey C Martin

iScience· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer.
Shruti D Shah, Bryan M Gillard, Michelle M Wrobel, Ellen Karasik, Michael T Moser

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartment.
Michalis Mastri, Swathi Ramakrishnan, Shruti D Shah, Ellen Karasik, Bryan M Gillard

Am J Clin Exp Urol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of WHSC1 Allows for Reprogramming of the Immune Compartment in Prostate Cancer.
Muzamil Y Want, Ellen Karasik, Bryan Gillard, A J Robert McGray, Sebastiano Battaglia

Int J Mol Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WHSC1/NSD2 regulates immune infiltration in prostate cancer.
Muzamil Y Want, Takemasa Tsuji, Prashant K Singh, James L Thorne, Junko Matsuzaki, Bryan Gillard

J Immunother Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer.
Marina P Antoch, Michelle Wrobel, Bryan Gillard, Karen K Kuropatwinski, Ilia Toshkov

Oncotarget· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy.
Hayley C Affronti, Aryn M Rowsam, Anthony J Pellerite, Spencer R Rosario, Mark D Long, Bryan M Gillard

Nat Commun· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.
Sebastiano Battaglia, Ellen Karasik, Bryan Gillard, Jennifer Williams, Trisha Winchester

Clin Epigenetics· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 model.
Hayley C Affronti, Mark D Long, Spencer R Rosario, Bryan M Gillard, Ellen Karasik

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical Models.
Mojgan Shourideh, Gissou Azabdaftari, Kristopher Attwood, Adam DePriest, Kristine M Wadosky, Bryan M Gillard

Clin Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic phenotype in CWR22 prostate cancer xenograft following castration.
Steven J Seedhouse, Hayley C Affronti, Ellen Karasik, Bryan M Gillard, Gissou Azabdaftari

Prostate· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The essential role of methylthioadenosine phosphorylase in prostate cancer.
Gaia Bistulfi, Hayley C Affronti, Barbara A Foster, Ellen Karasik, Bryan Gillard

Oncotarget· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genome-wide RNAi screen identifies FOXO4 as a metastasis-suppressor through counteracting PI3K/AKT signal pathway in prostate cancer.
Bing Su, Lingqiu Gao, Catherine Baranowski, Bryan Gillard, Jianmin Wang

PLoS One· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts.
Kiersten Marie Miles, Mukund Seshadri, Eric Ciamporcero, Remi Adelaiye, Bryan Gillard

PLoS One· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancer.
Adebusola Alagbala Ajibade, Jason S Kirk, Ellen Karasik, Bryan Gillard, Michael T Moser

PLoS One· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Src controls castration recurrence of CWR22 prostate cancer xenografts.
Bing Su, Bryan Gillard, Lingqiu Gao, Kevin H Eng, Irwin H Gelman

Cancer Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definition of molecular determinants of prostate cancer cell bone extravasation.
Steven R Barthel, Danielle L Hays, Erika M Yazawa, Matthew Opperman, Kempland C Walley, Bryan M Gillard

Cancer Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary folate deficiency blocks prostate cancer progression in the TRAMP model.
Gaia Bistulfi, Barbara A Foster, Ellen Karasik, Bryan Gillard, Jeff Miecznikowski

Cancer Prev Res (Phila)· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate.
Shannon R Morey Kinney, Wa Zhang, Marien Pascual, John M Greally, Bryan M Gillard

Cancer Prev Res (Phila)· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.
Ivy Chung, Guangzhou Han, Mukund Seshadri, Bryan M Gillard, Wei-dong Yu

Cancer Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis